美達股份(000782.SZ)上半年預盈4300萬元-4800萬元 同比扭虧
格隆匯7月14日丨美達股份(000782.SZ)披露2021年半年度業績預吿,公司預計2021年1-6月實現歸屬於上市公司股東的淨利潤4300萬元-4800萬元,上年同期為虧損4190.56萬元,同比實現扭虧為盈。
報吿期內,原材料價格處於攀升走勢,引導產品價格上漲,產品價格上漲幅度大於成本上漲幅度,產品毛利增加;疊加春節期間下游企業大部分開工,節假日需求比上年同期增加,市場熱銷行情帶動銷量增長。
公司抓住機遇,適時加大生產和銷售力度,平衡產銷,快進快出,實現公司產品量價齊升,報吿期毛利比去年同期增幅較大,公司扭虧為盈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.